MetLife, Inc. is a leading global provider of insurance, annuities, and employee benefit programs. The company operates through various segments, including U.S. Retail, Group Benefits, and International. Its core products encompass life insurance, health insurance, and retirement solutions. Major revenue sources include premiums from insurance policies, investment income, and fees from asset management services.
The investment profile of MetLife suggests it may appeal to value investors due to its stable dividend yield and established market position. The company has a history of consistent earnings, although recent revenue fluctuations may warrant caution. Overall, it presents a balanced opportunity for investors seeking income and potential capital appreciation.
| Date | Before | After | Reason |
|---|---|---|---|
| 2026-10-25 | Buy | Hold | Weak momentum and high risk offset potential upside. |
| 2026-10-23 | Hold | Buy | Strong momentum and solid fundamentals support growth potential. |
| 2026-10-15 | Buy | Hold | Solid fundamentals, but mixed momentum signals present uncertainty. |
| 2026-10-07 | Hold | Buy | Solid fundamentals, but mixed momentum signals. |
| 2026-09-30 | Buy | Hold | Mixed performance; cautious outlook amid market pressures. |
| 2026-08-16 | Hold | Buy | Solid fundamentals, but mixed momentum signals present uncertainty. |
| 2026-08-08 | Buy | Hold | Weak revenue growth raises concerns despite positive EPS surprise. |
| 2026-07-28 | Hold | Buy | Strong momentum and solid dividend yield support growth. |
| 2026-07-09 | Buy | Hold | Weak revenue growth raises concerns despite solid EPS surprise. |
| 2026-07-03 | Hold | Buy | Strong momentum but revenue decline raises concerns. |
| 2026-07-01 | Buy | Hold | Weak revenue growth raises concerns despite solid EPS. |
| 2026-06-27 | Hold | Buy | Solid fundamentals, but mixed momentum signals present risks. |
| 2026-06-25 | Buy | Hold | Weak revenue growth and negative short-term momentum. |
| 2026-06-23 | Hold | Buy | Mixed signals; strong momentum but revenue decline concerns. |
| 2026-06-19 | Buy | Hold | Weak revenue growth raises concerns despite solid EPS. |
| 2026-06-09 | Hold | Buy | Mixed performance; cautious due to revenue decline. |
| 2026-06-01 | Buy | Hold | Mixed performance; cautious outlook amid revenue decline. |
| 2026-05-16 | Hold | Buy | Stable dividend, but revenue decline raises concerns. |
| 2026-05-08 | — | Hold | Weak revenue growth raises concerns; hold for dividends. |
| 2026-05-08 | Buy | Buy | Компания MetLife демонстрирует умеренный рост за последние 20 дней, однако недавние падения и снижение выручки указывают на определенные риски. Уровень дивидендной доходности также привлекательный, что делает акцию интер |
| 2026-04-09 | Hold | Buy | Компания демонстрирует сильный рост выручки и положительную динамику цен на акции в краткосрочной перспективе. Дивидендная доходность также привлекательна, что делает акцию интересной для инвесторов. |
| 2026-02-24 | Buy | Hold | Компания демонстрирует стабильные финансовые показатели, однако недавнее снижение цены акций и высокая волатильность вызывают опасения. Рекомендуется удерживать акции до прояснения ситуации на рынке. |
| 2026-02-14 | Hold | Buy | Компания показывает стабильные финансовые результаты с хорошим ростом выручки, однако недавнее снижение цены акций и негативная динамика за 120 дней указывают на возможные риски. |
| Date | Analyst | Action | Target | Price Then |
|---|---|---|---|---|
| 2026-10-07 | Mizuho Securities | Target Lowered | 112 → 109 | 97.16 |
| 2026-10-07 | Barclays | Target Raised | 97 → 111 | 97.16 |
| 2026-10-06 | UBS | Target Raised | 105 → 110 | 96.88 |
| 2026-09-22 | Piper Sandler | Update | — → 110 | 96.64 |
| 2026-08-24 | Morgan Stanley | Target Raised | 103 → 111 | 95.75 |
| 2026-08-19 | Wells Fargo | Target Raised | 101 → 109 | 96.73 |
| 2026-08-06 | Barclays | Target Raised | 94 → 97 | 96.26 |
| 2026-07-15 | Atlantic Equities | Target Lowered | 106 → 103 | 92.44 |
| 2026-07-10 | Jefferies | Target Raised | 97 → 103 | 91.15 |
| 2026-07-08 | UBS | Target Raised | 102 → 105 | 90.27 |
| 2026-07-07 | Barclays | Target Raised | 93 → 94 | 90.46 |
| 2026-07-06 | Morgan Stanley | Target Raised | 93 → 103 | 90.93 |
| 2026-06-24 | Piper Sandler | Target Raised | 86 → 90 | 88.03 |
| 2026-05-26 | Piper Sandler | Target Raised | 81 → 86 | 84.06 |
| 2026-05-21 | Morgan Stanley | Target Raised | 89 → 93 | 83.5 |
| 2026-05-12 | Wells Fargo | Target Raised | 90 → 95 | 77.98 |
| 2026-05-08 | Mizuho Securities | Target Raised | 93 → 95 | 78.82 |
| 2026-05-07 | Barclays | Target Raised | 89 → 93 | 80.16 |
| 2026-04-13 | Mizuho Securities | Target Lowered | 100 → 93 | 74.63 |
| 2026-04-09 | Evercore ISI | Target Raised | 95 → 96 | 74.65 |
| 2026-04-09 | UBS | Target Raised | 98 → 102 | 74.65 |
| 2026-02-12 | Mizuho Securities | Target Lowered | 102 → 100 | 78.89 |
| 2026-02-10 | Evercore ISI | Target Lowered | — → 95 | 77.92 |
